Benitec Biopharma Ltd ADR (BNTC)

Benitec Biopharma Ltd ADR (BNTC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $335M; returns 1 day -1.9%, 1 week +6.7%, 1 year -45.3%.

Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the development of novel genetic medicines using its proprietary "Silence and Replace" DNA-directed RNA interference (ddRNAi) platform. This innovative technology combines gene therapy and RNA interference to simultaneously silence disease-causing genes and deliver wild-type replacement genes with a single administration.

Groups BNTC belongs to

• Biotechnology
• Clinical Stage Biotech
• Gene Therapy
• Life Sciences
• Healthcare
• Rare Diseases
• Biopharmaceutical
• R&D
• Commercial Stage Biotech
• Pharmaceuticals

BNTC financial model: income statement, cash flow and balance sheet